Position in BMRN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$28,301,239
+$4,608,715 QoQ
Shares Held
494,604
+17.9% QoQ
Ownership
0.256%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 561 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 82%
None 18%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. BMRN ranks #37 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in BMRN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,301,239 | 494,604 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $23,692,524 | 419,411 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $27,195,402 | 457,604 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $29,484,484 | 544,396 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $34,017,356 | 618,835 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $35,431,096 | 501,218 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $33,179,251 | 504,781 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $38,172,526 | 543,072 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $44,248,255 | 537,450 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $36,160,239 | 414,017 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $38,192,440 | 396,105 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $39,693,627 | 448,617 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $85,307,851 | 984,170 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $176,686,049 | 1,817,010 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $189,910,459 | 1,835,061 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $34,256,062 | 404,106 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $24,574,100 | 296,538 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $22,335,018 | 289,689 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $25,040,418 | 283,423 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $22,375,063 | 289,495 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $23,014,332 | 275,819 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $30,595,214 | 405,181 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $27,969,511 | 318,959 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $44,633,089 | 586,660 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $66,716,083 | 540,912 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $44,627,828 | 528,140 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||